首页|探究鞘内注射万古霉素与美罗培南治疗重症颅脑创伤术后颅内感染的临床疗效

探究鞘内注射万古霉素与美罗培南治疗重症颅脑创伤术后颅内感染的临床疗效

扫码查看
目的 分析重症颅脑创伤术后颅内感染患者使用万古霉素与美罗培南鞘内注射的治疗效果。方法 86 例重症颅脑创伤术后颅内感染患者作为研究对象,采用随机抽样法分成研究组和常规组,各 43 例。常规组患者使用万古霉素与美罗培南静脉滴注治疗,研究组使用万古霉素与美罗培南鞘内注射治疗。比较两组患者的临床疗效、不良反应发生率、并发症发生率、脑脊液指标、血清炎症因子、颅内压及症状消失时间、治愈时间、治疗费用。结果 研究组总有效率 97。67%高于常规组的 81。40%,差异性存在统计学意义(P<0。05)。研究组不良反应发生率 4。65%低于常规组的 20。93%,差异性存在统计学意义(P<0。05)。研究组并发症发生率 2。33%低于常规组的 16。28%,差异性存在统计学意义(P<0。05)。研究组症状消失时间、治愈时间、治疗费用分别为(6。06±1。14)d、(10。12±4。05)d、(1。64±0。73)万元,均少于常规组的(10。15±1。94)d、(24。12±10。23)d、(2。85±1。24)万元,差异性存在统计学意义(P<0。05)。研究组治疗后C反应蛋白、白细胞介素-6 水平分别为(8。18±1。46)mg/L、(16。03±2。32)ng/L,均低于常规组的(13。15±1。84)mg/L、(20。93±2。79)ng/L,差异性存在统计学意义(P<0。05)。研究组治疗后颅内压为(2。24±0。22)kPa,低于常规组的(2。68±0。51)kPa,差异性存在统计学意义(P<0。05)。研究组治疗后脑脊液葡萄糖水平(2。47±0。85)mmol/L高于常规组的(1。78±0。46)mmol/L,白细胞计数(355。60±280。26)×106/L、蛋白定量(1。36±1。05)g/L低于常规组的(601。60±312。07)×106/L、(2。28±1。06)g/L,差异性存在统计学意义(P<0。05)。结论 为重症颅脑创伤术后颅内感染患者使用万古霉素与美罗培南进行鞘内注射治疗,可以减轻血清炎性反应,改善脑脊液指标,还可减少并发症,降低颅内压,疗效显著,临床应用价值较高。
Clinical efficacy of intrathecal injection of vancomycin and meropenem in the treatment of intracranial infection after surgery for severe traumatic brain injury
Objective To analyze the effect of intrathecal injection of vancomycin and meropenem in the treatment of intracranial infection after surgery for severe traumatic brain injury.Methods A total of 86 patients with intracranial infection after surgery for severe traumatic brain injury were selected as the study subjects.The patients were randomly divided into a study group and a conventional group,each consisting of 44 patients.The conventional group received intravenous infusion of vancomycin and meropenem,while the study group received intrathecal injection of vancomycin and meropenem.The clinical efficacy,incidence of adverse reactions,complications,cerebrospinal fluid indicators,serum inflammatory factors,intracranial pressure,time for symptom disappearance,cure time,and treatment cost of the two groups were compared.Results The total effective rate of the study group was 97.67%,which was higher than 81.40%of the conventional group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions in the study group was 4.65%,which was lower than 20.93%in the conventional group,and the difference was statistically significant(P<0.05).The complication rate of the study group was 2.33%,which was lower than 16.28%of the conventional group,and the difference was statistically significant(P<0.05).The time for symptom disappearance,cure time and treatment cost in the study group were(6.06±1.14)d,(10.12±4.05)d and(1.64±0.73)ten thousand yuan,which were less than(10.15±1.94)d,(24.12±10.23)d and(2.85±1.24)ten thousand yuan in the conventional group.The difference was statistically significant(P<0.05).After treatment,the levels of C-reactive protein and interleukin-6 in the study group were(8.18±1.46)mg/L and(16.03±2.32)ng/L,which were lower than(13.15±1.84)mg/L and(20.93±2.79)ng/L in the conventional group,and the difference was statistically significant(P<0.05).After treatment,the intracranial pressure in the study groupwas(2.24±0.22)kPa,which was lower than(2.68±0.51)kPa in the conventional group,and the difference was statistically significant(P<0.05).After treatment,the study group had higher cerebrospinal fluid glucose of(2.47±0.85)mmol/L than(1.78±0.46)mmol/L in the conventional group;the study group had white blood cell count of(355.60±280.26)×106/L and protein quantification of(1.36±1.05)g/L,which were lower than(601.60±312.07)×106/L and(2.28±1.06)g/L in the conventional group;the difference was statistically significant(P<0.05).Conclusion Intrathecal injection of vancomycin and meropenem for patients with intracranial infection after surgery for severe traumatic brain injury can reduce serum inflammatory response,improve cerebrospinal fluid indicators,reduce complications,and reduce intracranial pressure in patients.The therapeutic effect is significant,and the clinical application value is high.

Intrathecal injectionVancomycinMeropenemSevere traumatic brain injuryIntracranial infection

聂磊

展开 >

274200 成武县人民医院神经外科

鞘内注射 万古霉素 美罗培南 重症颅脑创伤 颅内感染

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(13)
  • 20